top of page

iPROLEPSIS is a solution for psoriatic arthritis

The iPROLEPSIS project is where psoriatic arthritis inflammation is explained through multi-source data analysis guiding a novel personalized digital care ecosystem.

October 2023
Mon
Tue
Wed
Thu
Fri
Sat
Sun
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5

Upcoming events

Blue Abstract Shapes

Psoriatic Arthritis (PsA) is a 

chronic

progresive

inflammatory

disease affecting 1-2% of the general population, while manifesting in up to 30% of people with psoriasis (PsO).

Vision and impact.png

Project vision and impact

iPROLEPSIS is a HorizonEurope-funded project developing a novel personalised digital care ecosystem for people with PsA.

The goal of iPROLEPSIS is to propose a novel ecosystem that involves Real World Data (RWD) collection mechanisms and a powerful decision support system to provide new knowledge for the key actionable factors that affect the health-to-PsA transition, adopting a multiscale/ multifactorial approach, so, with the use of xAI-based models, to offer an efficient, effective, and clinically validated personalized digital care ecosystem for PsA patients.
Blue Abstract Shapes

Project objectives and work packages

iPROLEPSIS consortium works on 7 ambitious key objectives in the field of Psoriatic Arthritis (PsA) and has 6 Work Packages of the project that will bring together various and complementary expertise from consortium partners.

Blue Abstract Shapes

About project

15

Partners

9

Countries

48 m

Project duration

€ 6,4M

Total budget

The core activity domains

iProlepsis Core Activity domains.png

Establishment

• The foundation for the project’s research activities is laid by means of an extensive exploration of the available literature and data and the design of the clinical data collection and validation studies;

• Participatory design supporting the development of a user-oriented ecosystem of solutions will be employed to establish a framework for trustworthy AI-based R&D.

Validation

• The design and implementation of the clinical studies that will collect research data, validate the inflammatory symptoms digital biomarkers in individuals at risk of PsA and PSO patients, and evaluate the efficacy of the digital care tools with respect to prevention of inflammation exacerbation.

Research and development

• Research on multimodal data to reveal key PsA inflammation drivers, provide digital biomarkers of PsA inflammatory symptoms, and explore the effect of PsA on the joints and skin microvasculature, as well as the role of mast cells in PsA transition;

• Synthesise the outcomes into a multiscale/multifactorial model of the health-to-PsA transition;

• Deliver the integrated iPROLEPSIS digital health ecosystem comprising tools for personalised preventive PsA care, to empower patients and HCPs.

Contact us

We welcome your comments or questions about iPROLEPSIS project!​

browser-window-showing-person-working (1).png
bottom of page